3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is a key intermediate in pharmaceutical synthesis, particularly in the production of tyrosine kinase inhibitors (TKIs) such as nilotinib. Its structure features a trifluoromethyl-substituted benzene ring fused with a 4-methylimidazole moiety …
We'll support you, anytime.